Tighter regulations proposed for animal testing in UK

By Admin
A report by the Academy of Medical Sciences suggests that tighter regulations should be put in place for animal testing. The writers of the report are...

A report by the Academy of Medical Sciences suggests that tighter regulations should be put in place for animal testing.

The writers of the report are concerned by the increasing popularity of experiments involving the insertion of human materials into animals.

The report praises the benefits of the new technique, which has allowed researchers to test cancer drugs on human tissue attached to mice.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

However, it warns that the involvement of human materials increases the ethical complexity of animal testing. It suggests that current regulations are not always applicable.

For example, the Human Fertilisation and Embryology Authority prohibits the progression of any embryo that contains predominantly human material beyond 14 days. However, for embryos that are mostly animal but contain some human material, there are no regulations in place.

The report recommends three categories for studies involving animal testing, with category three experiments being banned.

The progression of the embryo containing some human material would be classified as a category three experiment.

Category two experiments would be assessed on a case-by-case basis, with the requirement that strong scientific justification must be provided. The addition of human genes to non-human primates would fall under this category.

Finally, category one experiments would be treated as any other test on an animal, with no additional regulations being imposed.

The UK government has said it will consider the proposal.

Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML